Preclinical studies of API Longolytin have been completed
Preclinical studies of API Longolytin have been successfully completed. Studies of toxicity and pharmacology have shown complete safety and efficiency of the drug.
Preclinical studies of API Longolytin have been successfully completed. Studies of toxicity and pharmacology have shown complete safety and efficiency of the drug.